Schwerpunkt Logo
AbbVie Inc. (ABBV : NYQ)
Sector: Healthcare | Industry: Drug Manufacturers - General
$289.08
+6.40 (+2.26%)
MARKET CAP
$510.84B
FCF YIELD
3.30%
CURRENT PRICE
$289.08
P/E RATIO
81.66x
Overview Financial Statements Metrics History DCF Valuation
FILTER LINE ITEMS:
INCOME STATEMENT (ANNUAL - 3-YEAR VIEW)
Financial Line Item 2025-12-31 2024-12-31 2023-12-31
1. REVENUE
Operating Revenue $61.16B $56.33B $54.32B
Total Revenue $61.16B $56.33B $54.32B
2. OPERATING EXPENSES
Reconciled Cost Of Revenue $18.20B $16.90B $20.41B
Interest Expense $2.89B $2.81B $2.22B
Tax Provision $2.36B $-570.00M $1.38B
Operating Expense $22.86B $27.54B $20.37B
Other Operating Expenses $-241.00M $-7.00M $-179.00M
Research And Development $9.10B $12.79B $7.67B
Selling General And Administration $14.01B $14.75B $12.87B
Cost Of Revenue $18.20B $16.90B $20.41B
Total Expenses $41.07B $44.44B $40.78B
3. NET INCOME & EARNINGS DETAILS
Tax Effect Of Unusual Items $-1.82B $-712.00M $-203.28M
Tax Rate For Calcs 35.83% 25.63% 22.00%
Normalized EBITDA $22.70B $17.69B $18.10B
Total Unusual Items $-5.07B $-2.78B $-924.00M
Total Unusual Items Excluding Goodwill $-5.07B $-2.78B $-924.00M
Net Income From Continuing Operation Net Minority Interest $4.23B $4.28B $4.86B
Reconciled Depreciation $8.14B $8.39B $8.70B
EBITDA $17.63B $14.91B $17.17B
EBIT $9.49B $6.52B $8.47B
Net Interest Income $-2.63B $-2.16B $-1.68B
Interest Income $266.00M $648.00M $540.00M
Normalized Income $7.48B $6.34B $5.58B
Net Income From Continuing And Discontinued Operation $4.23B $4.28B $4.86B
Total Operating Income As Reported $15.07B $9.14B $12.76B
Diluted Average Shares 1.77B 1.77B 1.77B
Basic Average Shares 1.77B 1.77B 1.77B
Diluted EPS $2.36 $2.39 $2.72
Basic EPS $2.39 $2.42 $2.75
Diluted NI Availto Com Stockholders $4.19B $4.24B $4.82B
Otherunder Preferred Stock Dividend $40.00M $40.00M $43.00M
Minority Interests $-7.00M $-8.00M $-10.00M
Net Income Including Noncontrolling Interests $4.23B $4.29B $4.87B
Net Income Continuous Operations $4.23B $4.29B $4.87B
Pretax Income $6.60B $3.72B $6.25B
Other Income Expense $-10.87B $-6.02B $-5.60B
Other Non Operating Income Expenses $-5.79B $-3.24B $-4.68B
Special Income Charges $-5.02B $-2.76B $-778.00M
Other Special Charges $5.02B $2.76B $778.00M
Gain On Sale Of Security $-58.00M $-21.00M $-146.00M
Net Non Operating Interest Income Expense $-2.63B $-2.16B $-1.68B
Interest Expense Non Operating $2.89B $2.81B $2.22B
Interest Income Non Operating $266.00M $648.00M $540.00M
Operating Income $20.09B $11.89B $13.54B
Gross Profit $42.96B $39.43B $33.90B
Net Income Common Stockholders $4.19B $4.24B $4.82B
Net Income $4.23B $4.28B $4.86B
FINANCIAL RATIOS & STATS
Financial Metric Value
Trailing P/E 81.66x
Forward P/E 17.84x
Price-to-Book (P/B) -86.06x
Price-to-Sales (P/S) 7.93x
Net Profit Margin (Net Income / Revenue) 9.80%
Operating Profit Margin (EBIT / Revenue) 40.03%
Return on Equity (ROE) N/A
Return on Assets (ROA) 10.51%
Dividend Rate $6.92
Dividend Yield 2.39%
Ex-Dividend Date 2026-10-15
Next Earnings Date 2026-10-30